The current management of IBD involves the use of various medications, including corticosteroids, aminosalicylates, immunosuppressive agents, antibiotics, oral small molecules, and biologics such as anti-tumor necrosis factor TNF-α [10]. The gene discussed is TNF; the disease is inflammatory bowel disease.